Format

Send to:

Choose Destination
See comment in PubMed Commons below
BMJ Case Rep. 2011 Feb 24;2011. pii: bcr1020103429. doi: 10.1136/bcr.10.2010.3429.

Antiretroviral therapy and cardiovascular risk.

Author information

  • 1Department of HIV Medicine, Chelsea and Westminster Hospital, London, UK. essra_ridha@hotmail.com

Abstract

The increase in the risk of myocardial infarction can be explained by antiretroviral-induced changes in conventional cardiovascular risk factors. Individual drugs within a drug class vary in their propensity to cause metabolic disturbances, and therefore, further studies are needed to determine the contribution of each drug to cardiovascular risk. A careful stratification of the cardiovascular risk and cardiovascular monitoring of HIV-infected individuals should be performed at baseline and at regular intervals during follow-up for this chronic medical condition. Standard primary and secondary prevention measures should be instituted in accordance with British Guidelines (Heart association, National Institute for Health and Clinical Excellence, etc for lipids, smoking and hypertension) Consideration of cardiovascular risk and drug-drug interactions when prescribing is crucial in the safe and optimum management of these patients. Careful communication between all care providers will help to avoid adverse outcomes.

PMID:
22707576
[PubMed - indexed for MEDLINE]
PMCID:
PMC3062864
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk